Yahoo Finance

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Prospective randomized ED study shows rapid bedside imaging, detection of critical neurological findings, and potential workflow efficiency benefits with portable MRI GUILFORD, Conn., May 22, ...

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Larom…

Founder, Chief Science Officer and Executive Chairman, Longeveron Poster Presentation at the 2026 Alzheimer’s Association ...

Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026

Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in ...
Nasdaq

Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology ...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
London South East

Scientific presentations on hyperpolarized Xenon

- Multiple hyperpolarized Xenon MRI presentations to be highlighted at two major upcoming scientific conferences Over 40 abstracts related to the use of hyperpolarized 129Xe were accepted for ...
Nasdaq

Leading Medical Physics Meeting to Feature More than 40 Presentations on ViewRay's MRIdian MRI-Guided Radiotherapy

CLEVELAND, July 10, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® System is the focus of more than 40 abstracts selected by the American Association of ...
Mena FN

Incision-Free, MRI-Guided Prostate Treatment With Profound's TULSA-PRO® To Be Featured In Multiple Presentations At The Upcoming 2026 Society Of Interventional Radiology ...

(MENAFN- GlobeNewsWire - Nasdaq) TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the“Company”), a commercial-stage medical device company that ...